Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 2/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 4/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | BLM | P54132 | 2/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.61 |
| ▸ | THRB | P10828 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | PLG | P00747 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.52 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.52 |
| ▸ | GABRP | O00591 | 1/20 | 0.52 |
| ▸ | GABRD | O14764 | 1/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18342688 | 0.98 | LMNA (0.65) | NFKB1CYP2D6LMNAKMT2ABLM | |
| SCHEMBL284981 | 0.92 | LMNA (0.62) | NFKB1CYP2D6LMNAKMT2ABLM | |
| Hydrochloric Acid SCHEMBL27636882 | 0.90 | LMNA (0.59) | NFKB1CYP2D6LMNAKMT2ABLM | |
| SCHEMBL9185822 | 0.87 | LMNA (0.53) | NFKB1CYP2D6LMNAKMT2AALDH1A1 | |
| SCHEMBL11438692 | 0.84 | TSHR (0.56) | NFKB1LMNAKMT2ATHRBMEN1 | |
| SCHEMBL6265240 | 0.84 | TSHR (0.56) | NFKB1LMNAKMT2ATHRBMEN1 | |
| SCHEMBL8751902 | 0.84 | TSHR (0.56) | NFKB1LMNAKMT2ATHRBMEN1 | |
| SCHEMBL3122983 | 0.82 | LMNA (0.43) | NFKB1CYP2D6LMNAKMT2ABLM | |
| SCHEMBL11276320 | 0.81 | — | — | |
| SCHEMBL503966 | 0.81 | LMNA (0.65) | NFKB1CYP2D6LMNAKMT2ABLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230022727-A1 | MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID | GENOMATICA INC (US) | 2023-01-26 | — | — | US | claimed |
| EP-2995925-B1 | COMPOSITION FOR HISTOCHEMICAL PROCESSING | VENTANA MED SYST INC (US) | 2021-12-15 | — | — | EP | claimed |
| US-20190330670-A1 | MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID | AGAIN BIO APS (DK) | 2019-10-31 | — | — | US | claimed |
| EP-2995925-A1 | COMPOSITION FOR HISTOCHEMICAL PROCESSING | Ventana Medical Systems, Inc. (US) | 2016-03-16 | — | — | EP | claimed |
| US-20140178929-A1 | COMPOSITIONS COMPRISING NANOMATERIALS AND METHOD FOR USING SUCH COMPOSITIONS FOR HISTOCHEMICAL PROCESSES | VENTANA MEDICAL SYSTEMS, INC. (US) | 2014-06-26 | — | — | US | claimed |
| US-8703490-B2 | Compositions comprising nanomaterials and method for using such compositions for histochemical processes | VENTANA MEDICAL SYSTEMS, INC. (US) | 2014-04-22 | — | — | US | claimed |
| US-20130303723-A1 | MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID | AGAIN BIO APS (DK) | 2013-11-14 | — | — | US | claimed |
| WO-2012177721-A1 | MICROORGANISMS FOR PRODUCING 6-AMINOCAPROIC ACID | GENOMATICA, INC. (US) | 2012-12-27 | — | — | WO | claimed |
| EP-2427544-A1 | MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID | Genomatica, Inc. (US) | 2012-03-14 | — | — | EP | claimed |
| US-20110091897-A1 | COMPOSITIONS COMPRISING NANOMATERIALS AND METHOD FOR USING SUCH COMPOSITIONS FOR HISTOCHEMICAL PROCESSES | VENTANA MEDICAL SYSTEMS, INC. | 2011-04-21 | — | — | US | claimed |
| EP-2300799-A2 | COMPOSITIONS COMPRISING NANOMATERIALS AND METHOD FOR USING SUCH COMPOSITIONS FOR HISTOCHEMICAL PROCESSES | Ventana Medical Systems, Inc. (US) | 2011-03-30 | — | — | EP | claimed |
| US-20100317069-A1 | MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID | AGAIN BIO APS (DK) | 2010-12-16 | — | — | US | claimed |
| WO-2010129936-A1 | MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID | GENOMATICA, INC. (US) | 2010-11-11 | — | — | WO | claimed |
| WO-2009149013-A2 | COMPOSITIONS COMPRISING NANOMATERIALS AND METHOD FOR USING SUCH COMPOSITIONS FOR HISTOCHEMICAL PROCESSES | VENTANA MEDICAL SYSTEMS, INC. (US) | 2009-12-10 | — | — | WO | claimed |
| US-20260028651-A1 | METHOD OF PRODUCING & PROCESSING DIAMINES | AGAIN BIO APS (DK) | 2026-01-29 | — | — | US | disclosed |
| US-12503711-B2 | Method of producing and processing diamines to a diamine free base using a carbonate intermediate and an engineered microorganism | GENOMATICA, INC. (US) | 2025-12-23 | — | — | US | disclosed |
| CN-114728871-B | Microorganisms and methods for reducing byproducts | 基因组股份公司 | 2024-12-27 | — | — | CN | disclosed |
| US-7713753-B2 | Dual-level self-assembled patterning method and apparatus fabricated using the method | SEAGATE TECHNOLOGY LLC (US) | 2010-05-11 | — | — | US | disclosed |
| US-20100051904-A1 | Dual-Level Self-Assembled Patterning Method and Apparatus Fabricated Using the Method | SEAGATE TECHNOLOGY LLC (US) | 2010-03-04 | — | — | US | disclosed |
| WO-2009149013-A2 | COMPOSITIONS COMPRISING NANOMATERIALS AND METHOD FOR USING SUCH COMPOSITIONS FOR HISTOCHEMICAL PROCESSES | VENTANA MEDICAL SYSTEMS, INC. (US) | 2009-12-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028651-A1 | METHOD OF PRODUCING & PROCESSING DIAMINES | DDC, DAO, ODC1 | NFKB1 2164/4885CYP2D6 1829/4885LMNA 2536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.